recent 1
advances 1
development 1
aurora 1
kinases 1
inhibitors 2
hematological 1
malignancies 1
treating 1
burkitt 1
lymphoma 5
adults 1
vitro 2
vivo 2
interactions 1
between 1
hdac 2
inhibitor 3
ricolinostat 1
acy 1
irreversible 1
proteasome 1
carfilzomib 1
nonhodgkin 1
cells 2
pikmtor 1
inhibition 1
markedly 1
potentiates 1
activity 1
nhl 1
through 2
bim 1
mcldependent 1
mechanisms 1
emerging 1
protein 1
kinase 1
treatment 1
nonhodgkins 2
hemophagocytic 1
lymphohistiocytosis 1
masquerading 1
progressive 1
chronic 1
lymphocytic 1
leukemia 1
phase 2
trial 1
eltrombopag 1
patients 2
undergoing 1
stem 1
cell 1
transplantation 1
total 1
body 1
irradiation 1
rituximab 1
indolent 1
lymphomas 1
natural 1
history 1
cns 1
relapse 1
aggressive 1
followup 1
analysis 1
swog 1
southwest 1
oncology 1
group 1
study 1
cladribine 1
cytarabine 1
arac 1
granulocyte 1
colony 1
stimulating 1
factor 1
gcsf 1
clag 1
regimen 1
simultaneous 1
escalating 1
doses 1
imatinib 1
mesylate 1
gleevec 1
relapsedrefractory 1
aml 1
targeting 1
follicular 1
microenvironment 1
blockade 1
tnfalpha 1
etanercept 1
